Treatment of Myelodysplastic syndrome with azacitidine and erythropoietin

被引:0
|
作者
Limaye, Sewanti [1 ]
Lipshitz, Jay [1 ]
Dulala, Renuka [1 ]
Patel, Dilip [1 ]
机构
[1] Long Isl Jewish Med Ctr, New Hyde Pk, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4627
引用
收藏
页码:230B / 230B
页数:1
相关论文
共 50 条
  • [1] Azacitidine for the treatment of myelodysplastic syndrome
    Cataldo, Vince D.
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 875 - 884
  • [2] Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome
    Komrokji, Rami S.
    Al Ali, Najla H.
    Alrawi, E.
    Padron, Eric
    Perkins, Janelle
    Field, Teresa
    Lancet, Jeffrey E.
    List, Alan F.
    BLOOD, 2011, 118 (21) : 745 - 746
  • [3] Treatment outcome of 5′-azacitidine for myelodysplastic syndrome
    Kim, Y. K.
    Kim, H. J.
    Song, J. E.
    Kim, S. E.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    LEUKEMIA RESEARCH, 2013, 37 : S110 - S110
  • [4] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Lin, Che-Hung
    Yeh, Su-Peng
    Lin, Tze-Yi
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1925 - 1926
  • [5] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Che-Hung Lin
    Su-Peng Yeh
    Tze-Yi Lin
    Annals of Hematology, 2015, 94 : 1925 - 1926
  • [6] Treatment of myelodysplastic syndrome: Questions raised by the azacitidine experience
    Kantarjian, HM
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2415 - 2416
  • [7] Treatment of Advanced Myelodysplastic Syndrome With Demethylating Agents: Azacitidine
    Ades, Lionel
    Itzykson, Raphael
    Fenaux, Pierre
    SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 323 - 329
  • [8] Approval summary: Azacitidine for treatment of myelodysplastic syndrome subtypes
    Kaminskas, E
    Farrell, A
    Abraham, S
    Baird, A
    Hsieh, LS
    Lee, SL
    Leighton, JK
    Patel, H
    Rahman, A
    Sridhara, R
    Wang, YC
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2005, 11 (10) : 3604 - 3608
  • [9] ERYTHROPOIETIN TREATMENT IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ANEMIA
    KURZROCK, R
    TALPAZ, M
    ESTEY, E
    OBRIEN, S
    ESTROV, Z
    GUTTERMAN, JU
    LEUKEMIA, 1991, 5 (11) : 985 - 990
  • [10] Azacitidine (Vidaza) for myelodysplastic syndrome
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1201): : 11 - 11